Emeritus Prof David Back

Professor Pharmacology & Therapeutics

    Research

    Research Group Membership

    Research Grants

    Pharmacologic strategies to use the levonorgestrel implant in HIV-infected women

    NATIONAL INSTITUTES OF HEALTH (USA)

    December 2015 - November 2020

    Protease inhibitors and drug disposition (PROCOM/FORTE Trial)

    MEDICAL RESEARCH COUNCIL

    October 1997 - December 2003

    Pharmacogenetic and pharmacokinetic studies.

    MONUMENT TRUST (UK)

    August 2005 - April 2011

    Modelling adherence, pharmacokinetics and treatment outcomes in HIV therapy.

    ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

    September 2003 - September 2008

    Therapeutic Drug Monitoring of Anti-HIV Drugs.

    MONUMENT TRUST (UK)

    October 1999 - September 2003

    Evaluation of the pharmacokinetics of Atripla with and without food in HIV-1 infected Ugandan adults.

    JOINT CLINICAL RESEARCH CENTRE (UGANDA)

    September 2010 - December 2012

    Effects within HAART on markers of adipose function.

    PENNINE ACUTE HOSPITALS NHS TRUST (UK)

    December 2005 - June 2009

    The pharmacology of HIV treatment failure.

    BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY (UK)

    October 2001 - December 2008

    Effects of NRTIs on adipose function.

    PENNINE ACUTE HOSPITALS NHS TRUST (UK)

    January 2006 - June 2009

    TAILoR (TelmisArtan and InsuLin Resistance in HIV): A dose-ranging Phase II randomised open trial of telmistartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on Combination Antiretroviral Therapy (CART)

    DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

    January 2012 - February 2020

    A pharmacokinetic evaluation of levonorgestrel implant and antiretroviral therapy.

    NATIONAL INSTITUTES OF HEALTH (USA)

    November 2013 - December 2016

    Modulation of TB-HIV drug interaction by host genetic influences

    MEDICAL RESEARCH COUNCIL

    July 2010 - June 2013

    Sub contractual agreement for multiple plasma sample tests agreement

    ST STEPHEN'S AIDS TRUST (UK)

    August 2009 - July 2012

    Population pharmacokinetic-pharmacodynamic modelling to optimise treatments for HIV,TB and malaria

    WELLCOME TRUST (UK)

    November 2008 - October 2012

    Detection of minority strains of HIV harbouring drug resistance.

    ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

    October 2002 - September 2005

    Therapeutic Drug Monitoring for HIV Protease Inhibitors.

    DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

    February 2000 - January 2003

    Influx and efflux transporters: a possible pharmacological determinant of HIV treatment failure.

    AVERT (UK)

    September 2000 - August 2003

    Understanding cellular resistance - an important link to understanding virological resistance.

    AVERT (UK)

    September 2001 - August 2004

    Assessment of TMC-278LA

    MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION (MWRIF) (USA)

    January 2012 - March 2017

    Liverpool Oxford Tropical Link (LOTLINK) in Clinical Pharmacology.

    WELLCOME TRUST (UK)

    January 2002 - December 2006

    A real time polymerase chain reaction machine and technical support.

    MONUMENT TRUST (UK)

    December 2003 - July 2006

    The Use of 'virtual' Inhibitory Quotients to Optimise HIV Treatment.

    DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

    January 2003 - December 2009

    St Stephens Aids Trust - SSAT trials

    ST STEPHEN'S AIDS TRUST (UK)

    April 2010 - March 2020

    HIV Research Trust Award for M Lamorde

    HIV RESEARCH TRUST (UK)

    May 2009 - July 2009

    Evaluation of the steady state pharmakinectics of second line antiretroviral drugs when administered under different meal conditions in HIV-infected Ugandan adults

    INFECTIOUS DISEASES INSTITUTE (UGANDA)

    September 2010 - December 2011

    Bioanalytical facility for drugs and small molecules

    ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

    July 2010 - June 2011